Uterine Leiomyosarcoma
📧 Sign up to get email alerts when something new happens for Uterine Leiomyosarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: Combined CRS With HIPEC in Women With Inadvertently Morcellated uLMS
A completed clinical trial evaluating cytoreductive surgery with HIPEC in women with inadvertently morcellated uterine leiomyosarcoma.
-
CLINICAL_TRIALS trial_result · 2024-05-28Clinical Trial Update: FUlvestrant in Gynecological Cancers That Are Potentially Hormone Sensitive: the FUCHSia Study [Phase 2]
A Phase 2 study (FUCHSia) evaluating fulvestrant for hormone-sensitive gynecologic cancers has completed, investigating its activity in uter…
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: A Phase II Clinical Trial Evaluating the Combination of Olaparib and Temozolomide for the Treatment of Advanced Uterine Leiomyosarcoma [Phase 2]
Phase II trial evaluating the combination of olaparib and temozolomide for advanced uterine leiomyosarcoma; results have been posted.
-
CLINICAL_TRIALS trial_result · 2021-12-30Clinical Trial Update: Study Comparing Efficacy of Doxorubicin With Trabectedin Followed by Trabectedin Versus Doxorubicine in Patients With Leiomyosarcoma [Phase 3]
Phase 3 trial comparing doxorubicin with trabectedin followed by trabectedin versus doxorubicine in leiomyosarcoma completed.
-
CLINICAL_TRIALS trial_result · 2020-05-12Clinical Trial Update: Nivolumab Alone or in Combination With Ipilimumab in Treating Patients With Advanced Uterine Leiomyosarcoma [Phase 2]
Phase 2 clinical trial evaluating nivolumab alone or in combination with ipilimumab in patients with advanced or unresectable uterine leiomy…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-04-06Clinical Trial Update: Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery [Phase 3]
Phase 3 trial investigating gemcitabine hydrochloride and docetaxel followed by doxorubicin hydrochloride or observation in high-risk uterin…
-
CLINICAL_TRIALS trial_result · 2019-07-23Clinical Trial Update: Sunitinib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus [Phase 2]
Phase 2 trial evaluating sunitinib in patients with recurrent or persistent uterine leiomyosarcoma and recurrent uterine sarcoma has complet…
-
CLINICAL_TRIALS trial_result · 2018-10-11Clinical Trial Update: Letrozole Versus Observation in Patients With Newly Diagnosed Uterine Leiomyosarcoma [Phase 2]
Phase 2 trial comparing letrozole to observation in newly diagnosed uterine leiomyosarcoma; trial terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2017-12-12Clinical Trial Update: Trabectedin in Treating Patients With Advanced, Persistent, or Recurrent Leiomyosarcoma of the Uterus [Phase 2]
Phase 2 trial results for trabectedin in patients with advanced, persistent, or recurrent uterine leiomyosarcoma have been posted. The study…
-
CLINICAL_TRIALS trial_result · 2017-12-06Clinical Trial Update: Activity of Trabectedin or Gemcitabine + Docetaxel in Uterine Leiomyosarcoma [Phase 2]
Phase 2 trial evaluating activity of trabectedin versus gemcitabine plus docetaxel in uterine leiomyosarcoma has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-14Clinical Trial Update: Multicenter Trial With PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecological Sarcomas and Mixed Epithelial-Mesenchymal Tumors [Phase 2]
Phase 2 multicenter study evaluating pegylated liposomal doxorubicin plus carboplatin in gynecologic mesenchymal tumors, including carcinosa…
-
CLINICAL_TRIALS trial_result · 2017-01-26Clinical Trial Update: Study of Doxorubicin and Trabectedin in First Line Treatment on Patients With Metastatic Leiomyosarcoma [Phase 2]
Phase 2 trial evaluating first-line Doxorubicin and Trabectedin in metastatic leiomyosarcoma has completed; results are not detailed in this…
-
CLINICAL_TRIALS trial_result · 2016-08-30Clinical Trial Update: Gemcitabine With or Without Docetaxel as Second-Line Therapy in Treating Patients With Metastatic or Relapsed, Unresectable Uterine or Soft Tissue Leiomyosarcoma [Phase 2]
Phase 2 trial evaluating gemcitabine with or without docetaxel as second-line therapy for metastatic or relapsed, unresectable uterine or so…
-
CLINICAL_TRIALS trial_result · 2015-12-22Clinical Trial Update: Adjuvant Docetaxel Plus Gemcitabine in Patients With Completely Resected Leiomyosarcoma (LMS) of the Uterus [NA]
This completed trial evaluated adjuvant docetaxel plus gemcitabine in patients with completely resected uterine leiomyosarcoma.
-
CLINICAL_TRIALS trial_result · 2015-07-30Clinical Trial Update: AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma [Phase 2]
A Phase 2 trial evaluating saracatinib (AZD0530) in adults with recurrent, locally advanced, or metastatic soft tissue sarcoma has completed…
-
CLINICAL_TRIALS trial_result · 2014-11-21Clinical Trial Update: Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma [Phase 2]
Phase 2 trial evaluating Ziv-aflibercept in locally advanced, unresectable, or metastatic gynecologic soft tissue sarcoma has completed with…
-
CLINICAL_TRIALS trial_result · 2014-03-19Clinical Trial Update: Letrozole in Women With Advanced Estrogen/Progesterone Receptor Positive Uterine Leiomyosarcoma [Phase 2]
Phase 2 trial of letrozole in women with advanced ER/PR-positive uterine leiomyosarcoma has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2014-02-14Clinical Trial Update: Docetaxel, Gemcitabine, and Filgrastim (G-CSF) or Pegfilgrastim in Treating Patients With Advanced, Persistent, or Recurrent Uterine Leiomyosarcoma [Phase 2]
A completed Phase 2 trial evaluating the combination of docetaxel, gemcitabine, and a G-CSF (filgrastim) or pegfilgrastim in patients with a…